GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Thursday, 18th Apr 2024 ABUS stock ended at $2.73. This is 1.80% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.72% from a day low at $2.69 to a day high of $2.79.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2021-05-28 $2.91 $2.96 $2.79 $2.83 961 861
2021-05-27 $2.81 $2.91 $2.79 $2.85 779 601
2021-05-26 $2.68 $2.87 $2.66 $2.78 874 513
2021-05-25 $2.70 $2.77 $2.67 $2.67 637 639
2021-05-24 $2.75 $2.77 $2.68 $2.70 1 070 007
2021-05-21 $2.80 $2.83 $2.72 $2.74 923 952
2021-05-20 $2.72 $2.83 $2.66 $2.78 887 328
2021-05-19 $2.74 $2.82 $2.67 $2.67 1 183 522
2021-05-18 $2.74 $2.88 $2.72 $2.81 830 324
2021-05-17 $2.66 $2.73 $2.57 $2.72 673 183
2021-05-14 $2.57 $2.67 $2.54 $2.62 719 585
2021-05-13 $2.75 $2.75 $2.43 $2.50 1 556 577
2021-05-12 $2.74 $2.87 $2.69 $2.72 836 795
2021-05-11 $2.53 $2.81 $2.45 $2.75 1 629 188
2021-05-10 $2.84 $2.85 $2.65 $2.65 1 288 409
2021-05-07 $2.83 $2.97 $2.80 $2.81 1 487 801
2021-05-06 $2.76 $2.86 $2.66 $2.80 3 227 318
2021-05-05 $3.22 $3.22 $2.94 $2.96 2 724 175
2021-05-04 $3.36 $3.42 $3.24 $3.33 1 874 211
2021-05-03 $3.55 $3.56 $3.38 $3.44 1 218 122
2021-04-30 $3.45 $3.57 $3.44 $3.47 949 812
2021-04-29 $3.43 $3.57 $3.37 $3.51 1 159 892
2021-04-28 $3.58 $3.58 $3.34 $3.42 1 287 327
2021-04-27 $3.36 $3.52 $3.33 $3.46 1 464 324
2021-04-26 $3.23 $3.37 $3.20 $3.28 1 178 848
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT